Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Unilever PLC (ULVRl)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4,162.1 -44.0    -1.06%
12:46:40 - Closed. Currency in GBP ( Disclaimer )
Type:  Equity
Market:  Euro Zone
ISIN:  GB00B10RZP78 
  • Volume: 1,521,362
  • Bid/Ask: 0.0 / 0.0
  • Day's Range: 4,118.3 - 4,166.5
Unilever 4,162.1 -44.0 -1.06%

ULVRl Financial Summary

 
A brief financial summary of Unilever PLC as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Unilever PLC reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 29,623 million compared to EUR 25,791 million a year ago. Net income was EUR 2,905 million compared to EUR 3,121 million a year ago. Basic earnings per share from continuing operations was EUR 1.14 compared to EUR 1.19 a year ago. Diluted earnings per share from continuing operations was EUR 1.13 compared to EUR 1.19 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ULVRl Income Statement

Gross margin TTM 46.23%
Operating margin TTM 17.5%
Net Profit margin TTM 10.36%
Return on Investment TTM 14.61%
 Total Revenue  Net Income
Period Ending: Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Total Revenue 14811.5 14811.5 13326.5
Gross Profit 14811.5 14811.5 -1803
Operating Income 2529.5 2529.5 2394
Net Income 1452.5 1452.5 1464

ULVRl Balance Sheet

Quick Ratio MRQ 0.47
Current Ratio MRQ 0.8
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 168.62%
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Total Assets 84892 84892 75095 75095
Total Liabilities 62026 62026 55349 55349
Total Equity 22866 22866 19746 19746

ULVRl Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  5.27%
 Cash  Net Change in Cash
Period Ending: Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 1524.5 1524.5 2464
Cash From Investing Activities -216 -216 -1338
Cash From Financing Activities -462 -462 -1501
Net Change in Cash 943.5 943.5 -342.5
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ULVR Comments

Write your thoughts about Unilever
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Frank Van den Brink
StormTrader Jun 10, 2022 3:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will go below 40. One board is not improving the results or the outlook.
RF RF
RF RF Mar 03, 2022 10:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
We therefore do not intend to pursue major acquisitions in the foreseeable future and will conduct a share buyback programme of up to €3 billion over the next two years.https://www.unilever.com/files/5b9872cf-337a-4bb4-9692-02a1b0a1b7fe/ir-q4-2021-full-announcement.pdf
Umberto Sandroni
Umberto Sandroni Jan 24, 2022 4:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
a BUY signal on Market Mìracle advisor with target 48.67
sinai levi
sinai levi Jan 19, 2022 7:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this a long-term short
Rohidas Kamath
Rohidas Kamath Jan 18, 2022 10:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I dont understand the mentality of investing public. uniliver plc went down yesterday even though its bid was rejected by gsk. today again it is down by nearly 3% for no reason. in fact uniliver plc should have recovered all the price of 7% that occured yesterday.
Alexander Lanzinger
Alexander Lanzinger Jan 18, 2022 10:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Its because unilever will raise its bid.
RF RF
RF RF Jan 18, 2022 10:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
no no
Rohidas Kamath
Rohidas Kamath Jan 18, 2022 8:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think uniliver plc is hell bent to persue takeover of consumer business from GSK against the wishes of majority shareholders. that is why share is beaten down.
Rohidas Kamath
Rohidas Kamath Jan 17, 2022 10:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
uniliver plc is victim of rumour mongers. when gsk has rejected the offer of uniliver plc where is the question of takeover of consumer division. shareholders are worried about higher consideration that may be offered by uniliver plc. under the circumstances it will be very difficult for uniliver plc to proceed further.
Rohidas Kamath
Rohidas Kamath Jan 17, 2022 9:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think market has realised that uniliver plc will find it very difficult to acquire consumer division of GSK. That is why share is recovering. in that way hindustan uniliver is lucky to grab the consumer division of gsk in 2020 itself. Great salute to management of hindustan uniliver in india.
Rohidas Kamath
Rohidas Kamath Jan 17, 2022 9:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
in my opinion gsk will not sell its consumer division at throw away price. it will be very difficult for uniliver plc to buy out gsk consumer division and at the end uniliver may drop the idea of buying gsk consumer division.
sinai levi
sinai levi Jan 17, 2022 6:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
the resistance will go down and all ****will go lose.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email